By now, every pharmacist and pharmacy intern licensed with the Ohio State Board of Pharmacy should have received a renewal application form in the mail.  Your license expires on September 15, 2001, so the renewal form (and the CPE reporting form if your license number begins with 03-1) must be received in this office by this date if you wish to continue to practice pharmacy in this state.  If you have not received your renewal application yet, please contact the Board office immediately.


If you are due to report continuing education this year, remember that the require­ments have increased.  You must submit at least 6.0 CEUs (60 hours) of continuing education, of which 4.5 CEUs (45 hours) must be in categories 01 or 02 (patient care) and 0.3 CEUs (3 hours) must be in category 03 Board-approved jurisprudence.




Please review the Board’s requirement for drug utilization review (DUR) as found in Rule 4729-5-20 of the Ohio Administrative Code that follows:   (emphasis added)


(A)    Prior to dispensing any prescription, a pharmacist shall review the patient profile for the purpose of identifying:

(1)    Over-utilization or under-utilization;

(2)    Therapeutic duplication;

(3)    Drug-disease state contraindications;

(4)    Drug-drug interactions;

(5)    Incorrect drug dosage;

(6)    Drug-allergy interactions;

(7)    Abuse/misuse;

(8)    Inappropriate duration of drug treatment;

(9)    Documented food-nutritional supplements-drug interaction.


(B)    Upon recognizing any of the above, a pharmacist, using professional judgment, shall take appropriate steps to avoid or resolve the potential problem.  These steps may include consulting with the prescriber and/or counseling the patient.


(C)    Prospective drug utilization review shall be performed using predetermined standards consistent with, but not limited to, any of the following:


(1)    Peer-reviewed medical literature (that is, scientific, medical, and pharmaceutical publications in which original manuscripts are rejected or published only after having been critically reviewed by unbiased independent experts);


(2)    American Hospital Formulary Service Drug Information;


(3)    United States Pharmacopoeia Drug Information;


(4)    American Medical Association evaluations.


Please note that the rule requires a PHARMACIST to review the profile.  This requirement applies to ALL prescriptions, both new and refill.  Too many pharmacists rely solely on the pharmacy computer system to do this review for them.  The computer can do a decent job of reviewing the medication history, but it is dependent upon the parameters that are set when the program is installed or adjusted.  As we have found, too often the computer system’s parameters are set incorrectly and interactions, misuse/abuse, and therapeutic duplications are not being caught by the computer.  When this happens, the pharmacist is still held accountable for the results.  Blaming the computer is not appropriate.


We have also found that some pharmacies have patients who have multiple profiles instead of just one.  Often, this occurs when the patient has a Workers Compensation claim and is also being treated by a family physician.  Please remember that the patient’s profile consists of the total list of drugs obtained, not just the drugs on an arbitrarily defined profile.  Obviously, the computer system check does not usually run on more than one profile.  When this situation occurs, the pharmacist must see that a DUR is performed on all profiles for the patient.


Finally, since the DUR is to be performed by a pharmacist, it is inappropriate for a technician or other clerical helper to override any computer DUR warning that may occur.  The pharmacist is required to perform all professional functions in the filling of a prescription and may not delegate them to anyone who is not a pharmacist.  When the DUR warnings appear on the computer screen, the pharmacist must make the decision about the appropriate action to take.  Please be sure that any technicians who are entering prescription data into the computer system understand this requirement.




Due to two bills that were approved by the Legislature last session, the Board has issued new rules dealing with consult agreements and pharmacists administering immunizations.  The consult rules took effect on June 1, 2001, and the immunization rules were effective on July 1, 2001.  The full text of these rule changes can be found on our Web site at by clicking on “What’s New?” and then clicking on "Rules Effective in 2001 Showing Changes".




Anyone having a question regarding the license status of a particular practitioner, nurse, pharmacist, pharmacy intern, or dangerous drug distributor in Ohio should con­tact the appropriate licensing board.  The Web sites listed below may include disciplinary actions for their respective licensees.


State Dental Board--614/466-2580,

State Medical Board--614/466-3934,

State Nursing Board--614/466-3947,

State Optometry Board--614/466-5115,

State Pharmacy Board--614/466-4143,

State Veterinary Medical Board--614/644-5281,

Drug Enforcement Administration--800/230-6844;




The disciplinary actions listed below include only those where the individual’s license to practice has been suspended, revoked, or restricted and does not include any other actions taken by the Board.  All actions may be seen in the minutes of the meetings, which are posted on the Board's Web site (go to the address above then click on "Board Minutes").


Orders of the Board:


Jerry N. Liliestedt, R.Ph.; North Canton - Placed on probation 4 years effective 06/14/01 and may not serve as a preceptor or train pharmacy interns, or serve as a responsible pharmacist while on probation.


Daniel Paul Poignon, R.Ph.; Toledo - License revoked effective 12/18/00.


Stanley Shaw Scarbrough, R.Ph.; Findlay - License placed on probation for 5 years effective 01/12/01 and may not serve as a preceptor or train pharmacy interns while on probation.


Settlement Agreement:


Roger K. Elliott, R.Ph.; Zanesville- License suspended indefinitely effective 04/04/01 and may not be employed by or work in a facility licensed by the Board while suspended.


Summary Suspensions:  [Sec. 3719.121 of the Revised Code]


Katherine R. Carson, R.Ph.; Mentor.  Effective 06/05/01.


Kevin Chakos, R.Ph.; Cleveland.  Effective 05/15/01.


Michelle M. Solnosky, R.Ph.; Euclid.  Effective 04/13/01.




A document of legal actions taken by the Medical Board may be accessed on the Internet at the Medical Board's Web site (go to the address above then click on "Monthly Formal Actions").  If you would like a more detailed history of a legal action for an individual practitioner, go "Back" to the Medical Board's Home page, click on the "Licensee Profile & Status" tag, then follow the instructions.  Please contact the Medical Board if you have questions.